Published in Clin Infect Dis on June 01, 2000
Infections caused by Scedosporium spp. Clin Microbiol Rev (2008) 2.69
Treatment of scedosporiosis with voriconazole: clinical experience with 107 patients. Antimicrob Agents Chemother (2008) 1.69
Correlation between in vitro susceptibility of Scedosporium apiospermum to voriconazole and in vivo outcome of scedosporiosis in guinea pigs. Antimicrob Agents Chemother (2004) 1.16
Voriconazole in the treatment of invasive mold infections in transplant recipients. Eur J Clin Microbiol Infect Dis (2003) 1.03
Infection of the CNS by Scedosporium apiospermum after near drowning. Report of a fatal case and analysis of its confounding factors. J Clin Pathol (2004) 0.95
Pseudallescheria boydii cranial osteomyelitis and subdural empyema successfully treated with voriconazole: a case report and literature review. Eur J Clin Microbiol Infect Dis (2004) 0.89
Histological examination of an eye with endogenous Aspergillus endophthalmitis treated with oral voriconazole: a case report. Graefes Arch Clin Exp Ophthalmol (2004) 0.89
Voriconazole in the management of nosocomial invasive fungal infections. Ther Clin Risk Manag (2006) 0.86
Invasive infection caused by Pseudallescheria boydii in an immunocompetent patient. Hippokratia (2009) 0.75
tRNA punctuation model of RNA processing in human mitochondria. Nature (1981) 8.48
Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest (1994) 5.12
Association of Escherichia coli HEp-2 adherence patterns with type and duration of diarrhoea. Lancet (1991) 4.52
A point mutation in the 14alpha-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus. Antimicrob Agents Chemother (2003) 3.17
Distinctive features of the 5'-terminal sequences of the human mitochondrial mRNAs. Nature (1981) 3.01
Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother (1996) 2.91
Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs. Antimicrob Agents Chemother (1994) 2.87
Identification of two different 14-alpha sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species. J Clin Microbiol (2001) 2.87
Human mtDNA haplogroups associated with high or reduced spermatozoa motility. Am J Hum Genet (2000) 2.64
The pattern of transcription of the human mitochondrial rRNA genes reveals two overlapping transcription units. Cell (1983) 2.60
Mesoscale vertical motion and the size structure of phytoplankton in the ocean. Nature (2001) 2.60
Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J Clin Microbiol (2008) 2.57
Identification of initiation sites for heavy-strand and light-strand transcription in human mitochondrial DNA. Proc Natl Acad Sci U S A (1982) 2.55
Substitutions at methionine 220 in the 14alpha-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. Antimicrob Agents Chemother (2004) 2.51
Heparin in acute stroke with atrial fibrillation: clinical relevance of very early treatment. Arch Neurol (1999) 2.47
Effect of grapefruit juice on blood cyclosporin concentration. Lancet (1995) 2.33
Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother (1995) 2.19
Paraoxonase2 polymorphisms are associated with nephropathy in Type II diabetes. Diabetologia (2001) 2.18
Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study. Am J Respir Crit Care Med (1998) 2.17
Typing and characterization of mechanisms of resistance of Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania. J Clin Microbiol (1999) 2.11
Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med (1995) 2.08
Salmonella enterica serovar virchow with CTX-M-like beta-lactamase in Spain. J Clin Microbiol (2000) 2.04
Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes (Lond) (2011) 2.00
Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii. J Antimicrob Chemother (1997) 1.97
Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology (1993) 1.95
Risk factors for lower airway bacterial colonization in chronic bronchitis. Eur Respir J (1999) 1.93
[Minimal intervention in smoking in the outpatient pneumonology consultation]. Arch Bronconeumol (1994) 1.91
Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med (1995) 1.88
Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi. J Antimicrob Chemother (2002) 1.87
Evidence for a circadian rhythm of insulin secretion. Am J Physiol (1996) 1.86
Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. Gut (2000) 1.82
Idiopathic stabbing headache (jabs and jolts syndrome) Cephalalgia (1996) 1.82
Gastrointestinal leishmaniasis in human immunodeficiency virus-infected patients: report of five cases and review. Clin Infect Dis (1994) 1.82
A small polyadenylated RNA (7 S RNA), containing a putative ribosome attachment site, maps near the origin of human mitochondrial DNA replication. J Mol Biol (1981) 1.71
Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest (1997) 1.71
[new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic]. Med Clin (Barc) (1998) 1.70
Sequence analysis and precise mapping of the 3' ends of HeLa cell mitochondrial ribosomal RNAs. J Mol Biol (1982) 1.67
Targeted gene disruption of the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility. Antimicrob Agents Chemother (2005) 1.66
In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans. Antimicrob Agents Chemother (2000) 1.61
Inhibition of localized adhesion of enteropathogenic Escherichia coli to HEp-2 cells by immunoglobulin and oligosaccharide fractions of human colostrum and breast milk. J Infect Dis (1991) 1.60
International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole. J Clin Microbiol (2005) 1.55
Diagnosis of brucellosis by using blood cultures. J Clin Microbiol (1997) 1.53
The putative mRNA for subunit II of human cytochrome c oxidase starts directly at the translation initiator codon. Nature (1980) 1.49
Incidence and prevalence of the metabolic syndrome in a cohort of naive HIV-infected patients: prospective analysis at 48 weeks of highly active antiretroviral therapy. Int J STD AIDS (2007) 1.48
[Limb shaking and loss of consciousness: a carotid-basilar artery syndrome]. Neurologia (1995) 1.44
Impact of early central venous catheter removal on outcome in patients with candidaemia. Clin Microbiol Infect (2007) 1.43
Colorectal adenocarcinoma: quality of the assessment of lymph node metastases. Dis Colon Rectum (1994) 1.42
Veno-occlusive hepatic disease of the liver in renal transplantation: is azathioprine the cause? Nephron (1989) 1.41
Genetic Structure of Rhizobium etli biovar phaseoli Associated with Wild and Cultivated Bean Plants (Phaseolus vulgaris and Phaseolus coccineus) in Morelos, Mexico. Appl Environ Microbiol (1994) 1.40
[Study of the Eustachian valve using two-dimensional echocardiography]. Rev Esp Cardiol (1988) 1.39
[Temporal threshold for middle cerebral artery infarction]. Neurologia (1995) 1.39
[The restless legs syndrome and periodic sleep movements as the initial manifestation of iron-deficiency anemia]. Med Clin (Barc) (1994) 1.39
Iron status in patients receiving erythropoietin for dialysis-associated anemia. Kidney Int (1989) 1.39
Recurrent pulmonary embolism. A prospective study. Chest (1989) 1.39
[The white coat effect in primary care. Analysis of patients with newly diagnosed arterial hypertension]. Med Clin (Barc) (1997) 1.39
Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates. J Antimicrob Chemother (1999) 1.39
Confusional syndrome as the presenting form of calcium pyrophosphate dihydrate deposition disease. Br J Rheumatol (1992) 1.38
Correlation of sperm motility with mitochondrial enzymatic activities. Clin Chem (1998) 1.37
Hurricane disturbance and tropical tree species diversity. Science (2000) 1.36
Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain. Antimicrob Agents Chemother (1995) 1.35
The strange case of the earliest silver extraction by European colonists in the New World. Proc Natl Acad Sci U S A (2007) 1.34
Decreased permeability and enhanced proton-dependent active efflux in the development of resistance to quinolones in Morganella morganii. Int J Antimicrob Agents (2000) 1.33
Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain. J Clin Microbiol (1999) 1.32
Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clin Microbiol Infect (2007) 1.32
Cloning and nucleotide sequence analysis of a gene encoding an OXA-derived beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother (1997) 1.32
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain. Antimicrob Agents Chemother (2008) 1.29
Increased phosphoinositide 3-kinase activity induces a lymphoproliferative disorder and contributes to tumor generation in vivo. FASEB J (2000) 1.28
In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates. Antimicrob Agents Chemother (1996) 1.28
Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus. Diabetologia (2004) 1.26
Mutation screening of the PPARalpha gene in type 2 diabetes associated with coronary heart disease. Diabetes Metab (2000) 1.26
Decreased invasive capacity of quinolone-resistant Escherichia coli in patients with urinary tract infections. Clin Infect Dis (2001) 1.26
Correlation between the procedure for antifungal susceptibility testing for Candida spp. of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and four commercial techniques. Clin Microbiol Infect (2005) 1.25
Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study. Chest (1991) 1.24
Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study. J Clin Microbiol (2005) 1.20
Direct regulation of mitochondrial RNA synthesis by thyroid hormone. Mol Cell Biol (1999) 1.19
Early prediction of stroke severity. Role of the erythrocyte sedimentation rate. Stroke (1995) 1.17
Circadian regulation of islet genes involved in insulin production and secretion. Mol Cell Endocrinol (2004) 1.16
Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patients. HIV Med (2006) 1.16
DNA barcoding in Mucorales: an inventory of biodiversity. Persoonia (2013) 1.16
Skin colonization by Corynebacterium groups D2 and JK in hospitalized patients. J Clin Microbiol (1988) 1.13
Didelphis marsupialis, an important reservoir of Trypanosoma (Schizotrypanum) cruzi and Leishmania (Leishmania) chagasi in Colombia. Am J Trop Med Hyg (1994) 1.13
Increase in quinolone resistance in a Haemophilus influenzae strain isolated from a patient with recurrent respiratory infections treated with ofloxacin. Antimicrob Agents Chemother (1999) 1.12
Predictors of mortality in patients with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia: the role of empiric antibiotic therapy. Eur J Clin Microbiol Infect Dis (2007) 1.12
Effects of prolonged glucose infusion on insulin secretion, clearance, and action in normal subjects. Am J Physiol (1996) 1.11
Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study. Clin Infect Dis (2005) 1.11
4E binding protein 1 expression is inversely correlated to the progression of gastrointestinal cancers. Int J Biochem Cell Biol (2000) 1.11
Familial multiple symmetric lipomatosis associated with the A8344G mutation of mitochondrial DNA. Neurology (1998) 1.09
Mechanism of mammalian mitochondrial DNA replication: import of mitochondrial transcription factor A into isolated mitochondria stimulates 7S DNA synthesis. Nucleic Acids Res (2001) 1.09
Six-year prospective study of risk and prognostic factors in patients with nosocomial sepsis caused by Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis (1999) 1.08
[Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication. Follow-up of the histological and molecular response]. Med Clin (Barc) (1998) 1.08
Improved method of determining the susceptibility of Candida albicans to fluconazole. J Antimicrob Chemother (1995) 1.08
Tiotropium improves FEV1 in patients with COPD irrespective of smoking status. Pulm Pharmacol Ther (2007) 1.07
Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region. Eur J Clin Microbiol Infect Dis (2005) 1.07
Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukemic patients. J Clin Microbiol (1995) 1.07
Treatment of Absidia corymbifera infection in mice with amphotericin B and itraconazole. J Antimicrob Chemother (2001) 1.06
Knock-knock: a population-based survey of risk behavior, health care access, and Chlamydia trachomatis infection among low-income women in the San Francisco Bay area. J Infect Dis (2001) 1.05
In vitro susceptibility of Cryptococcus gattii clinical isolates. Clin Microbiol Infect (2008) 1.05